Truvestments Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$837K |
| 2 |
Enbridge
ENB
|
+$643K |
| 3 |
AbbVie
ABBV
|
+$597K |
| 4 |
Invesco
IVZ
|
+$518K |
| 5 |
CVS Health
CVS
|
+$501K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Europe ETF
VGK
|
+$1.23M |
| 2 |
WisdomTree Emerging Markets High Dividend Fund
DEM
|
+$1M |
| 3 |
Blackstone
BX
|
+$893K |
| 4 |
Vanguard Value ETF
VTV
|
+$869K |
| 5 |
Vanguard Growth ETF
VUG
|
+$304K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.14% |
| 2 | Healthcare | 10.85% |
| 3 | Consumer Staples | 8.36% |
| 4 | Industrials | 8.19% |
| 5 | Communication Services | 7.21% |
Similar funds
Truvestments Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Truvestments Capital held 807 positions worth $149M, up 14% from $130M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Truvestments Capital deployed $15.4M of net new capital in Q2 2019, opening 78 new positions and adding to 152 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 4,043 shares worth $862K.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Vanguard FTSE Europe ETF, an estimated $1.23M trimmed.
- Truvestments Capital's largest Q2 2019 buy was Berkshire Hathaway Class B: 4,043 shares worth $862K.
- Truvestments Capital added most to Enbridge in Q2 2019, an estimated $643K increase.
- Truvestments Capital's biggest Q2 2019 reduction was Vanguard FTSE Europe ETF, cutting an estimated $1.23M.
- Truvestments Capital fully exited Blackstone in Q2 2019, selling an estimated $893K.
- Truvestments Capital's ten largest holdings make up 23% of its $149M portfolio in Q2 2019.
- Truvestments Capital opened 78 new positions and closed 88 in Q2 2019.
- Truvestments Capital's portfolio value rose 14% quarter-over-quarter to $149M.
Based on Truvestments Capital's 13F filing for Q2 2019, filed 15 Jul 2019.